Cancer Diagnostics Market

Cancer Diagnostics Market

Cancer Diagnostics Market by Test type - Tumour Biomarkers Tests, Imaging, Biopsy, Liquid Biopsy, Immunohistochemistry and In Situ Hybridization for 2021 - 2031

  • XPLREP805

  • March, 2021

  • 285 Pages

  • Cancer

Escalating fatalities due to Cancer Driving the Cancer Diagnostics Market

As per a report published on XploreMR, the global cancer diagnostics market is expected to grow two-fold in the years to come.

The ever-increasing incidences of oncologic cases, technological upgradations in diagnostics on the continuous basis, and growing demand for proper screening tests are amongst the prime factors driving the cancer diagnostics market across the globe. Governments around the world are also supporting cancer diagnostics-related initiatives, which acts as another booster to the market.

It is a well-known fact that cancer accounts for a major portion of fatalities all across. As such, the healthcare personnel are emphasizing on developing proper diagnostic as well as treatment solutions for checking the level of prevalence. The fact that detection at early stages results in increase in success rates of the treatment regimens also calls for spurt in cancer diagnostics.

Though screening procedures like imaging, endoscopy or even lab tests do facilitate early detection, the risks involved in medical imaging procedures like exposure to radiation, administration of barium contrast and fluorescent media can’t be ruled out. Plus, cost incurred in having these diagnostic procedures conducted is high. These factors are bound to restrain the cancer diagnostics market in the forecast period.

What are Products up to?

Imaging modalities like MRI and CT scan are non-invasive, painless, and quick diagnostic solutions. They are being used in the form of supportive tests with the other genetic and laboratory tests for determining severity and location of condition in the diagnosis of various kinds of cancer. The cancer specialists could select the mode of treatment accordingly.

Laboratory tests are inclusive of testing urine, blood, or the other body fluids, or even tissues for checking presence of biomarkers, whereas the genetic tests comprise genetic aberrations in RNA and DNA samples taken from the tumours. Proper medical diagnosis can’t be ascertained on performing either genetic testing or laboratory testing alone. So, specialists go for simultaneous means, i.e. performing genetic and laboratory testing at the same time, so that the further course of treatment could be accurate.

How about Application-based Market Revenue?

Out of the kinds of cancers prevalent, breast cancer is found to hold the largest market share. The screening test employed over here is “mammography”. The USPSTF (United States Preventive Services Task Force) states that women aged 50 and above (upper limit could be 74) turn out to be at the highest risk of contracting breast cancer. As a constructive measure, the same USPSTF does recommend women aged 40 and above to go for mammography at regular intervals (say – 2 years).

On the other note, the increasing consumption of alcohol and tobacco in the developing economies of Asia-Pacific is increasing the risk of tumours in kidney and liver. This factor is expected to increase the demand for kidney and liver screening in the upcoming period.

What do Regions have to Say?

North America holds more than 50% of the market share due to extra heed being paid to healthcare, with people being benevolent regarding cancer diagnostics. The region is also quick to adopt advanced technologies, which paves the way for growth. Europe functions along the similar lines and stands second. Asia-Pacific is expected to grow at the fastest rate due to increase in medical tourism in the countries like Malaysia, China, and India (apart from the reasons mentioned above).

Though the outbreak of Covid-19 has temporary stalled the research being conducted in this field, once normalcy is restored (probably at the start of 2021), the research would be “bang on”.

Competitive Landscape

The key players in the cancer diagnostics market include Illumina, Inc., Becton, Dickinson & Company,  Hologic, Inc., GE Healthcare, F. Hoffmann-La Roche Ltd., Abbott, and Koninklijke Philips N.V.

Important Questions Answered

  • What is the growth potential of the Cancer diagnostics Market?
  • Which company is currently leading the Cancer diagnostics Market? Will the company continue with the winning streak during the forecast period?
  • What are the top strategies that players are expected to adopt in the years to come?
  • Which regional market is anticipated to secure the highest market share?
  • How will the competitive landscape change in future?
  • What do players need to do to adapt to future competitive changes?
  • What will be the total production and consumption with regards to Cancer diagnostics by 2030?
  • Which are the key upcoming technologies? How will they impact the Cancer diagnostics Market?
  • Which product segment is expected to show the highest CAGR?
  • Which application is forecast to gain the biggest market share?

Highlights of TOC:

Overview: Along with a broad overview of the Cancer diagnostics Market, this section gives an overview of the report to give an idea about the nature and contents of the research study.

Market Dynamics: Here, the authors of the report have comprehensively discussed about key drivers, restraints, challenges, trends, and opportunities of the Cancer diagnostics Market.

Product Segments: This part of the report throws light on the market growth of several types of products sold by leading companies.

Application Segments: The analysts authoring the report have deeply assessed the market potential of key applications and identified future opportunities they are expected to create in the Cancer diagnostics Market.

Geographical Segments: Each regional market is carefully looked into for understanding its current and future growth scenarios.

Company Profiles: Top players of the Cancer diagnostics Market are thoroughly profiled in the report based on their market share, market served, products, applications, regional growth, and other factors.

A recent market study published by XploreMR on the Cancer Diagnostics Market offers global industry analysis for 2016-2020 & opportunity assessment for 2021-2031. The report consists of a comprehensive assessment of the most important market dynamics. On conducting thorough research on the historical as well as current growth parameters of the cancer diagnostics market, growth prospects of the market are obtained with maximum precision. The report features unique and salient factors that may make a huge impact on the development of the cancer diagnostics market during the forecast period. It can help market players modify their manufacturing and marketing strategies to envisage maximum growth in the cancer diagnostics market in the coming years. The report provides detailed information about the current and future growth prospects of the cancer diagnostics market in the most comprehensive way for a better understanding of readers.

Key Segments of Cancer Diagnostics Market

XploreMR’s study on the cancer diagnostics market offers information divided into four important segments - Test Type, Indication, End User and Region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Test Type

  • Tumor Biomarkers Tests
    • PSA Tests
    • CTC Tests
    • AFP Tests
    • CA Tests
    • HER2 Tests
    • BRCA Tests
    • ALK Tests
    • CEA Tests
    • EGFR Mutation Tests
    • KRAS Mutation Tests
    • Others
  • Imaging
    • Ultrasound
    • Mammography
    • MRI Scan
    • PET Scan
    • CT Scan
    • SPECT & Others
  • Biopsy
    • Needle Biopsy
    • Endoscopic Biopsy
    • Bone Marrow Biopsy
    • Others
  • Liquid Biopsy
  • Immunohistochemistry
  • In Situ Hybridization

Indication

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Melanoma
  • Blood Cancer
  • Prostate Cancer
  • Ovarian Cancer
  • Stomach Cancer
  • Liver Cancer
  • Others

End User

  • Hospital Associated Labs
  • Independent Diagnostic Laboratories
  • Diagnostic Imaging Centers
  • Cancer Research Institutes
  • Others

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East and Africa

Chapter 1 – Executive Summary

The report commences with the executive summary of the cancer diagnostics market report, which includes the summary of key findings and statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the cancer diagnostics market as well as the key trends impacting the market.

Chapter 2 – Market Overview

Readers can find detailed taxonomy and product definition of the cancer diagnostics market, in this chapter, which helps readers understand basic information about cancer diagnostics.

Chapter 3 – Market Background

This chapter explains the key macroeconomic factors that are expected to influence the growth of the cancer diagnostics market during the forecast period. The chapter also highlights the major forecast factors that will shape market growth. Besides, it provides key dynamics of the cancer diagnostics market, which include the drivers, restraints, and opportunity analysis. This chapter is expected to enable readers to understand the factors that are propelling the growth of the cancer diagnostics market, as well as those that are likely to hamper the growth of the cancer diagnostics market. The opportunity analysis for the cancer diagnostics will help readers understand the market opportunities, based on which they can plan their strategies.

Chapter 4 – Market Context

This chapter explains the key regulations and reimbursement scenario in various countries along with disease epidemiology that is expected to influence the growth of the cancer diagnostics market during the forecast period.

Chapter 5 – COVID19 Crisis Analysis

This section provides the current and expected impact of COVID19 on the cancer diagnostics market.

Chapter 6 – Global Cancer Diagnostics Market Value (US$) Analysis 2015-2019 and Forecast 2020-2030

This section explains the global market value analysis and forecast for the Cancer Diagnostics Market during the forecast period. Along with the historical market and opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2020), and an incremental $ opportunity for the forecast period (2020–2030).

Chapter 7 – Global Cancer Diagnostics Market Analysis 2015-2019 & Opportunity Assessment, 2020-2030, By Test Type

Based on therapy, the Cancer Diagnostics Market is segmented Tumor Biomarkers Tests (PSA Tests, CTC Tests, AFP Tests, CA Tests, HER2 Tests, BRCA Tests, ALK Tests, CEA Tests, EGFR Mutation Tests, KRAS Mutation Tests, Others), Imaging (Ultrasound, Mammography, MRI Scan, PET Scan, CT Scan, SPECT & Others), Biopsy (Needle Biopsy, Endoscopic Biopsy, Bone Marrow Biopsy, Others), Liquid Biopsy, Immunohistochemistry and In Situ Hybridization. In this chapter, readers can find information on market attractive analysis based on therapy.

Chapter 8 – Global Cancer Diagnostics Market Analysis (2015-2019) & Opportunity Assessment (2020-2030), By Indication

Based on indication, the cancer diagnostics market is segmented into Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, Blood Cancer, Prostate Cancer, Ovarian Cancer, Stomach Cancer, Liver Cancer and Others. In this chapter, readers can find information on market attractive analysis based on the indication.

Chapter 9 – Global Cancer Diagnostics Market Analysis 2015-2019 & Opportunity Assessment, 2020-2030, By End User

Based on the end user, the Cancer Diagnostics Market is segmented into Hospital Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes and Others. In this chapter, readers can find information on market attractive analysis based on the end user.

Chapter 10 – Global Cancer Diagnostics Market Analysis 2015-2019 & Opportunity Assessment 2020-2030, By Region

This chapter explains how the Cancer Diagnostics Market will grow across various geographic regions such as North America, Latin America, Europe, East Asia, south Asia, Oceania, and the Middle East & Africa (MEA).

Chapter 11 – North America Cancer Diagnostics Market Analysis 2015-2019 & Opportunity Assessment 2020-2030

This chapter includes a detailed analysis of the growth of the North America cancer diagnostics market along with the country-wise assessment including the U.S. and Canada. Readers can also find key takeaways of this region, and market growth based on Indication, therapy, and country of cancer diagnostics in the North American region.

Chapter 12 – Latin America Cancer Diagnostics Market Analysis 2015-2019 & Opportunity Assessment 2020-2030

This chapter includes the growth prospects of the cancer diagnostics market in leading countries such as Brazil, Mexico, Argentina and the rest of Latin America. Readers can find thorough information about the growth parameters of the Latin America cancer diagnostics market during 2020-2030.

Chapter 13 – Europe Cancer Diagnostics Market Analysis 2015-2019 & Opportunity Assessment 2020-2030

Important growth prospects of the Cancer Diagnostics Market based on Indication, adoption, and country in several European countries such as the U.K., Germany, France, Italy, Spain, Russia, and the Rest of Europe are included in this chapter.

Chapter 14 – South Asia Cancer Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030

India, Indonesia, Malaysia, Thailand, and the rest of South Asia are the leading countries/regions in South Asia that are the prime subjects of assessment to obtain the growth prospects of the South Asia Cancer Diagnostics Market, in this chapter, readers can find thorough information about the growth parameters of the South Asia Cancer Diagnostics Market during 2030.

Chapter 15 – East Asia Cancer Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030

Detailed information about factors such as incremental opportunity, Y-O-Y growth, and regional trends that are impacting the growth of the East Asia Cancer Diagnostics Market are included in this chapter. It also includes the growth prospects of the Cancer Diagnostics Market in leading East Asian countries such as China, Japan, and South Korea.

Chapter 16– Oceania Cancer Diagnostics Market Analysis 2015–2019 and Forecast 2020–2030

This chapter consists of important parameters that have a huge impact on the growth of the Cancer Diagnostics Market in Oceania, based on market segmentation, during the forecast period. The chapter also provides an overview of the drivers, restraints, and trends in the Oceania Cancer Diagnostics Market.

Chapter 17 – MEA Cancer Diagnostics Market Analysis 2015-2019 & Opportunity Assessment 2020-2030

This chapter provides information on how the Cancer Diagnostics Market will grow in the major countries in the MEA region, such as GCC Countries, South Africa, Turkey and the Rest of MEA during 2020-2030.

Chapter 18 – Key and Emerging Countries Cancer Diagnostics Market Analysis 2015-2019 & Opportunity Assessment 2020-2030

This chapter provides information on how the Cancer Diagnostics Market will grow in the major countries across the world during 2020-2030.

Chapter 19 – Market Structure Analysis

This chapter highlights the tier structure analysis, market concentration analysis and company share analysis along with sales footprint analysis of key player operating in cancer diagnostics market.

Chapter 20 – Competition Analysis

In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the cancer diagnostics market, along with a detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are Abbott Laboratories, Roche, Thermo Fisher Scientific Inc., Siemens AG, Bio Rad Laboratories Inc., Illumina, Inc., Koninklijke Philips N.V., Canon Medical Systems Corporation, Agilent Technologies Inc. and among others

Chapter 21 – Assumptions and Acronyms Used

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.

Chapter 22 – Research Methodology

This chapter helps readers understand the research methodology followed to obtain various conclusions, important qualitative information, and quantitative information about the cancer diagnostics market.

Sources and Primary Research Splits (%)

Industry Interactions

Key Designations

  • C - Level Executives
  • Marketing Directors
  • Product Managers
  • Business Development Officers
  • Production Managers
  • Procurement Heads
  • Sales Executives

Stakeholder Category

  • Distributors
  • Traders
  • Raw Material Suppliers
  • Industry Experts
  • Consumptions

Questions

  • Current Market Dynamics and Challenges
  • Yesteryear Trends
  • Market Characteristics
  • Market Performance and Growth Quadrants
  • Competition Structure and Market Structure
  • Strategic Growth Initiatives
  • Near-term and Long-term Market Growth Prospects
  • Market Segment Splits and Authenticity
  • Opinions on Market Projections and Validity of Assumptions

References Catalogue

  • Industry Publications
    • World Health Organizations (WHO)
    • National Institute of Health (NIH)
    • Centers for Disease Control and Prevention (CDC)
  • Factiva
  • Company Press Releases
  • Oncology Journals
  • Annual Reports and Investor Presentations
  • Research Papers
  • Government Websites and Publications
  • Company Websites,
  • Morningstar
  • GLOBOCON,2020
Purchase Options
Cancer Diagnostics Market by Test type - Tumour Biomarkers Tests, Imaging, Biopsy, Liquid Biopsy, Immunohistochemistry and In Situ Hybridization for 2021 - 2031
Buy Now
Custom Market Research Services

Custom Market Research Services

xploreMR offers custom market reserch services that help clients to get information on their business scenario required where syndicated solutions are not enough

Why Choose XploreMR

Why Choose XploreMR
  • Analyst Support

    Our analysts go above and beyond to answer your specific queries. We are with you throughout the entire journey – from initial discussion to post-purchase.

  • Country-wise Analysis & Forecasting

    As we track markets at country-level, we are able to offer hard-to-find market intelligence in both developed and emerging countries.

  • High Quality At Competitive Pricing

    We believe high quality market research shouldn’t be out of reach for businesses. Our competitively-priced market research reports ensure businesses of all sizes have access to quality information

Popular Reports

report
Cancer Biomarkers Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025

Cancer Biomarkers Market- Scope of the Report The recent study by XploreMR on cancer biomarkers market offers a 5-year forecast between 2020 and 2025. The study analyzes crucial trends that ...

report
Global Market Study on Bile Duct Cancer (Cholangiocarcinoma) Treatment: North America & Europe to Hold over ~30% Market Share During 2017-2025

Report Introduction The report ‘Bile Duct Cancer (Cholangiocarcinoma) Treatment Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025)’ is a comprehensive compilation ...